CYP1A1 and breast carcinoma: The selectivity of probe 5 was demonstrated on breast cancer cell lines (MDA-MB-231 cells), showing significant fluorescence, and indicating a higher concentration of CYP1A1 in breast cancer cells, as illustrated in Fig. 5A and B.